CONNECTs

Our programmes

  • See All
  • Podcast
  • Experts knowledge share
  • E-learning
  • Video
  • Publication
  • Other

Episode

1

of 2

episode
Hemato-oncology 
Update from ASH 2019

Episode 1

Experts
Prof. Alexey V Danilov
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer

Episode

2

of 2

episode
Hemato-oncology 
Update from ASH 2019

Episode 2

Experts
Dr Jessica Okosun
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer
Hemato-oncology 
Update from ASCO 2019

LYMPHOMA CONNECT has summarised highlights of the recent ASCO 2019 meeting

Experts
Prof. Paul M Barr
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer
Hemato-oncology 
Update from ASCO and EHA 2021 on Multiple Myeloma

Dr Hans Lee summarises the latest news in multiple myeloma from the ASCO and EHA 2021 virtual meetings.

Experts
Asst. Prof. Hans Lee
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Karyopharm

Episode

2

of 2

episode
Hemato-oncology 
Update from ASH 2018

Episode 2

Experts
Prof. Stefano Luminari
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer

Episode

1

of 2

episode
Hemato-oncology 
Update from ASH 2018

Episode 1

Experts
Assoc. Prof. Loretta Nastoupil
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer
Hemato-oncology 
Highlights in Multiple Myeloma

Dr. María-Victoria Mateos discusses Highlights in Multiple Myeloma (MM), focusing on recent developments in the treatment of triple- or penta-refractory MM.

Experts
Assoc. Prof. María Victoria Mateos
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Karyopharm
podcast Podcast

Episode

1

of 3

episode
Hemato-oncology 
Choosing the Best Treatment Regimen in NDMM

Episode 1: Choosing the Best Treatment Regimen in NDMM

Experts
Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Oct 2021

Educational programme supported by an Independent Medical Education grant from Karyopharm
podcast Podcast

Episode

2

of 3

episode
Hemato-oncology 
Choosing the Best Treatment Regimen in RRMM

Episode 2: Choosing the Best Treatment Regimen in RRMM

Experts
Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Oct 2021

Educational programme supported by an Independent Medical Education grant from Karyopharm
Hemato-oncology 
Update from the 2021 Autumn Congresses in Multiple Myeloma

Dr Claudio Cerchione summarises highlights from SOHO, SOHO Italy and IMW 2021

Experts
Dr Claudio Cerchione
  • download Downloadable
    Resources
  • clock 10 MIN
  • calendar Nov 2021

Educational programme supported by an Independent Medical Education grant from Karyopharm
podcast Podcast

Episode

3

of 3

episode
Hemato-oncology 
Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics

Episode 3: Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics

Experts
Assoc. Prof. María Victoria Mateos, Dr Alexander M Lesokhin
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Mar 2022

Educational programme supported by an Independent Medical Education grant from Karyopharm
Oncology 
Update From ASCO 2022 – Selected LBAs

COR2ED brings you an update on the late breaker plenary sessions from ASCO 2022

Experts
Dr Rebecca Dent, Prof. Chiara Cremolini, Asst. Prof. Hans Lee, Prof. Jonathan Trent
  • clock 7 MIN
  • calendar May 2022

Hemato-oncology 
Update from ASCO 2022 – Myeloma

Dr Hans Lee summarises the highlights from the phase 3 DETERMINATION trial: Lenalidomide, bortezomib, and dexamethasone (RVd) ± autologous stem cell transplantation (ASCT) and R maintenance to progression for newly diagnosed multiple myeloma (NDMM)

Experts
Asst. Prof. Hans Lee
  • clock 2 MIN
  • calendar May 2022

Oncology 
COR2ED at ESMO 2022

We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022.  In 10 years,  500,000 healthcare professionals have trusted our educational programmes.

  • clock 2 MIN
  • calendar Sep 2022

Oncology 
Update From ESMO 2022 Presidential Sessions

COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.

Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo
  • clock 10 MIN
  • calendar Sep 2022

Oncology Hemato-oncology 
Update From ASH 2022

Highlights from the ASH Annual Meeting

Experts
Dr Matthew J. Matasar
  • clock 4 MIN
  • calendar Dec 2022

Educational programme supported by an Independent Medical Education grant from COR2ED.